Pediatric Oncology and the Impact of Molecular

Dr. Jeffrey C. Allen, M.D. is a dad and a doctor. The experience of his own child getting sick with cancer had a profound impact on his career. He discusses the progress that’s been made in pediatric oncology and its next frontier: molecular therapy.

Jeffrey C. Allen, M.D., currently serves as Otto and Marguerite Manley and Making Headway Foundation & Endowed Professor of Pediatric Neuro-oncology at NYU Langone Medical Center. Dr. Allen’s medical specialties include Cancer, Pediatric Neurology, Neurology, Pediatrics, and Pediatric Hematology-Oncology. His medical expertise includes Pediatric Neurology, Neuro-Oncology, Brain Tumors, Pediatric Hematology/Oncology, Brain/Spinal Cord Tumors, Pediatric Neuro-Oncology, and Brain Cancer. Dr. Allen is board certified and a Diplomate of the American Board of Psychiatry and Neurology with Special Competence in Child Neurology. He received his Doctor of Medicine from Harvard University and completed his Residency in Pediatrics at Montreal Children’s Hospital.

Subscribe

Get the latest insights from the world’s knowledge marketplace

Thank you for subscribing!